Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice

Genetic Vaccines and Therapy

Volumn 6, Issue , 2008, Pages

  Pacak, Christina A ^a   Sakai, Yoshihisa ^a   Thattaliyath, Bijoy D ^a   Mah, Cathryn S ^a   Byrne, Barry J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DESMIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN LIGHT CHAIN 2; PARVOVIRUS VECTOR; TROPONIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SPECIFICITY; ENZYME ACTIVITY; GENE ACTIVITY; GENE EXPRESSION; HEART MUSCLE CELL; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PROMOTER REGION; SYSTEMIC THERAPY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

MIRIDAE; MUS;

EID: 53349176758     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-6-13     Document Type: Article

References (23)

1. Thierry AR Lunardi-Iskandar Y Bryant JL Rabinovich P Gallo RC Mahan LC Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice Proc Natl Acad Sci USA 1995, 92:9742-9746. 40878 7568209 10.1073/pnas.92.21.9742
2. Clark KR Sferra TJ Johnson PR Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle Hum Gene Ther 1997, 8:659-669. 10.1089/hum.1997.8.6-659 9113506
3. Kessler PD Podsakoff GM Chen X McQuiston SA Colosi PC Matelis LA Kurtzman GJ Byrne BJ Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci USA 1996, 93:14082-14087. 19498 8943064 10.1073/ pnas.93.24.14082
4. Podsakoff G Wong KK Jr Chatterjee S Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors J Virol 1994, 68:5656-5666. 236967 8057446
5. Xiao X Li J Samulski RJ Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996, 70:8098-8108. 190884 8892935
6. Mah C Cresawn KO Fraites TJ Jr Pacak CA Lewis MA Zolotukhin I Byrne BJ Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors Gene Ther 2005, 12:1405-1409. 10.1038/sj.gt.3302550 15920463
7. Mah C Pacak CA Cresawn KO Deruisseau LR Germain S Lewis MA Cloutier DA Fuller DD Byrne BJ Physiological Correction of Pompe Disease by Systemic Delivery of Adeno-associated Virus Serotype 1 Vectors Mol Ther 2007, 15:501-507. 10.1038/sj.mt.6300100 17245350
8. Pacak CA Mah CS Thattaliyath BD Conlon TJ Lewis MA Cloutier DE Zolotukhin I Tarantal AF Byrne BJ Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo Circ Res 2006, 99:e3-9. 10.1161/01.RES.0000237661.18885.f6 16873720
9. Inagaki K Fuess S Storm TA Gibson GA McTiernan CF Kay MA Nakai H Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8 Mol Ther 2006, 14:45-53. 1564441 16713360 10.1016/j.ymthe.2006.03.014
10. Sarkar R Mucci M Addya S Tetreault R Bellinger DA Nichols TC Kazazian HH Jr Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice Hum Gene Ther 2006, 17:427-439. 10.1089/ hum.2006.17.427 16610930
11. Vandendriessche T Thorrez L Acosta-Sanchez A Petrus I Wang L Ma L L DEW Iwasaki Y Gillijns V Wilson JM et al. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy J Thromb Haemost 2007, 5:16-24. 10.1111/j.1538-7836.2006.02220.x 17002653
12. Brunskill EW Witte DP Yutzey KE Potter SS Novel Cell Lines Promote the Discovery of Genes Involved in Early Heart Development Developmental Biology 2001, 235:507-520. 10.1006/dbio.2001.0313 11437454
13. Loser P Jennings GS Strauss M Sandig V Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFkappaB J Virol 1998, 72:180-190. 109363 9420214
14. Catalogue of Regulatory Elements http://www.cbil.upenn.edu/MTIR/TOC.html
15. Paulin D Li Z Desmin: A major intermediate filament protein essential for the structural integrity and function of muscle Exp Cell Res 2004, 301:1-7. 10.1016/j.yexcr.2004.08.004 15501438
16. Wallenberg Human Protein Atlas 2006
17. James J Osinska H Hewett TE Kimball T Klevitsky R Witt S Hall DG Gulick J Robbins J Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology Transgenic Res 1999, 8:9-22. 10.1023/ A:1008894507995 10399364
18. Kim SJ Iizuka K Kelly RA Geng YJ Bishop SP Yang G Kudej A McConnell BK Seidman CE Seidman JG Vatner SF An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes Am J Physiol 1999, 276:H1780-1787. 10330263
19. Aikawa R Huggins GS Snyder RO Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction J Biol Chem 2002, 277:18979-18985. 10.1074/jbc.M201257200 11889137
20. Henderson SA Spencer M Sen A Kumar C Siddiqui MA Chien KR Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression J Biol Chem 1989, 264:18142-18148. 2808370
21. Kelly R Buckingham M Manipulating myosin light chain 2 isoforms in vivo: a transgenic approach to understanding contractile protein diversity Circ Res 1997, 80:751-753. 9130457
22. Ip HS Wilson DB Heikinheimo M Tang Z Ting CN Simon MC Leiden JM Parmacek MS The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells Mol Cell Biol 1994, 14:7517-7526. 359288 7935467
23. Sands MS Barker JE Percutaneous intravenous injection in neonatal mice Lab Anim Sci 1999, 49:328-330. 10403452